Diabetes medication intensification — USMLE Step 3 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Add a GLP-1 receptor agonist or SGLT2 inhibitor with cardiovascular benefit
Type 2 diabetes with ASCVD should include agents with cardiovascular benefit, individualized to kidney function, weight, and patient factors.
Reference: American Diabetes Association Standards of Care in Diabetes—2026: https://professional.diabetes.org/standards-of-care